Sale!

Breast Cancer Biomarker Profile (ER, PR, HER-2, Ki-67)

Original price was: R6,700.Current price is: R4,700.

-30%

Facing a breast cancer diagnosis can feel overwhelming, but understanding your specific cancer type is the first step toward effective treatment. Our comprehensive Breast Cancer Biomarker Profile analyses four crucial markers – ER, PR, HER-2, and Ki-67 – to provide your oncologist with essential information for creating a personalised treatment plan. This advanced testing helps determine whether your cancer responds to hormone therapy, targeted treatments, or requires more aggressive approaches. For only ZAR 4,700 (regularly ZAR 6,700), you gain access to precise, laboratory-grade analysis that could significantly impact your treatment success. With results in just 10 days and nationwide coverage including Johannesburg, Cape Town, and Durban, we make this critical testing accessible when you need it most. Trust our experienced pathologists to deliver the accurate, reliable results your healthcare team depends on for making informed decisions about your care.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

Breast Cancer Biomarker Test ZAR 4
Breast Cancer Biomarker Profile (ER, PR, HER-2, Ki-67)
R6,700 Original price was: R6,700.R4,700Current price is: R4,700.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding Your Breast Cancer Journey Starts Here

Receiving a breast cancer diagnosis can be one of life’s most challenging moments, filled with uncertainty and questions about what comes next. We understand that having clear, accurate information about your specific cancer type is essential for making informed decisions about your treatment. Our comprehensive Breast Cancer Biomarker Profile provides the critical insights your oncologist needs to develop a treatment plan tailored specifically to your cancer’s characteristics.

What This Essential Test Reveals About Your Cancer

This advanced analysis examines four key biomarkers that determine how your breast cancer behaves and responds to treatment:

  • ER (Oestrogen Receptor): Determines if your cancer grows in response to oestrogen
  • PR (Progesterone Receptor): Identifies if progesterone fuels cancer growth
  • HER-2 (Human Epidermal Growth Factor Receptor 2): Reveals if targeted therapies will be effective
  • Ki-67: Measures how quickly cancer cells are dividing

Each of these markers provides crucial information that directly impacts which treatments will work best for your specific situation, helping avoid ineffective therapies and unnecessary side effects.

Who Should Consider This Comprehensive Testing?

This test is essential for anyone recently diagnosed with breast cancer or those whose treatment isn’t progressing as expected. If you’re experiencing:

  • Recent breast cancer diagnosis requiring treatment planning
  • Uncertainty about which treatment options will be most effective
  • Need for personalised therapy based on your cancer’s specific characteristics
  • Desire to understand your cancer’s aggressiveness and growth patterns
  • Previous inconclusive biomarker results requiring confirmation

This testing provides the clarity needed to move forward with confidence in your treatment journey.

Why This Testing Matters for Your Health Journey

Understanding your cancer’s biomarker profile isn’t just about getting information – it’s about getting the right treatment from the start. This comprehensive analysis helps:

  • Personalise Your Treatment: Identifies which therapies will target your specific cancer type
  • Avoid Unnecessary Treatments: Prevents using medications that won’t work for your cancer
  • Improve Treatment Outcomes: Increases the likelihood of successful treatment response
  • Reduce Side Effects: Helps choose treatments with the best benefit-to-risk ratio
  • Provide Peace of Mind: Gives you and your family confidence in your treatment plan

Understanding Your Results with Confidence

Your results will provide clear, detailed information about each biomarker, presented in a format your oncologist can easily interpret. Our experienced pathologists review every sample to ensure accuracy, and we include professional interpretation to help you understand what each result means for your treatment options. Remember – these results are designed to empower your healthcare team with the information needed to create the most effective treatment strategy for you.

Investment in Your Health Journey

Service Regular Price Special Price
Comprehensive Breast Cancer Biomarker Profile ZAR 6,700 ZAR 4,700

This investment provides essential information that could save thousands in ineffective treatments and, more importantly, guide you toward the most appropriate care for your specific situation.

Nationwide Access to Essential Cancer Testing

We’re committed to making this critical testing accessible across South Africa. With collection points and partnerships in major centres including Johannesburg, Cape Town, Durban, and Pretoria, we ensure you can access this essential testing regardless of your location. Our streamlined process makes it easy to get the information you need without unnecessary delays.

Take the Next Step in Your Treatment Journey

Don’t let uncertainty about your cancer’s characteristics delay your treatment planning. This comprehensive biomarker analysis provides the clarity needed to move forward with confidence. With results available in just 10 days and the peace of mind that comes from working with trusted laboratory professionals, you can take control of your health journey today.

Book your Breast Cancer Biomarker Profile now for ZAR 4,700 and give your healthcare team the essential information needed to create your personalised treatment plan.

Sample Requirements: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.